University College London: Early Success in Developing World-first Gene Therapy for Devastating Immune Disorder
June 26, 2026
June 26, 2026
LONDON, England, June 26 -- The University College London posted the following news:
* * *
Early success in developing world-first gene therapy for devastating immune disorder
The development of a pioneering gene therapy to treat a devastating, rare immune disorder led by UCL scientists is set to move into its next phase following promising early pre-clinical studies.
CTLA-4 insufficiency is a rare disease of the white blood cells that normally . . .
* * *
Early success in developing world-first gene therapy for devastating immune disorder
The development of a pioneering gene therapy to treat a devastating, rare immune disorder led by UCL scientists is set to move into its next phase following promising early pre-clinical studies.
CTLA-4 insufficiency is a rare disease of the white blood cells that normally . . .